Time to approve UK clinical trials has more than halved, says MHRA The Medicines and Healthcare products Regulatory Agency said the introduction of AI methods had contributed to quicker approval times.…
GPhC proposes increasing pharmacy technicians’ level of study A consultation document has outlined proposals to raise the level of pharmacy technicians’ roles to Regulated Qualifications Framework level 4 in England and Scottish Credit and Qualifications Framework level 7 in Scotland.…
Regulator fails on timeliness standard for fitness-to-practise cases for seventh year in a row The Professional Standards Authority said that while the General Pharmaceutical Council is reducing its aged fitness-to-practise cases, the end-to-end median time from referral to final decision has increased.…
Creating effective assessment activities for foundation trainees This article shows how designated prescribing practitioners and designated supervisors can use the GPhC learning outcomes and NHS England assessment strategy to plan effective activities for foundation trainees.…
RPS urges patients to seek medicines information from ‘trusted source’ after Trump links paracetamol and autism The president of the Royal Pharmaceutical Society urged anyone with concerns about their medicines to speak to a pharmacist or a trusted healthcare professional.…
GPhC appoints Chris Askew as interim chief executive The former chief executive of the Royal College of General Practitioners will take up the role on 1 October 2025.…
GPhC reveals draft criteria to cut record number of fitness-to-practise concerns The General Pharmaceutical Council said that concerns raised have doubled over the past five years, from 2,989 in 2020/2021 to 6,202 in 2024/2025.…
Yellow Card reporting to be taught across schools in England The Medicines and Healthcare products Regulatory Agency's Yellow Card scheme enables people to report an adverse event or side effect relating to medicines and medical devices in the UK.…
Investigations ongoing as regulator takes action against Jhoots The General Pharmaceutical Council's enforcement action against Jhoots follows concerns raised about unexpected closures and ‘poor service’ in several branches.…
MHRA approves first new UTI antibiotic in 30 years Gepotidacin (Blujepa; GSK) is approved for the treatment of uncomplicated UTIs in patients aged 12 years and over, who weigh at least 40kg.…
